Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
How to evaluate the investment The framework we use at Perfect B for evaluating whether peptide therapy is the right investment is straightforward: what is the clinical goal, is there a peptide mechanism that directly addresses it, and does the patients baseline health profile support that mechanism working as intended
Lin, C.-C
A 2026 study (PMID 41418663) used IGF-1 LR3 as the therapeutic agent in a rat volumetric muscle loss (VML) model, delivering the peptide via poly(lactic-co-glycolic acid) microencapsulation within a polyethylene glycol-acrylate hydrogel void filler
& Niwayama, S
Qualitative assessment of nitric oxide production by fluorescent dye 3-Amino-4-aminomethyl-2,7-difluorescein, diacetate (DAF-FM DA, Sigma) HUVECs grown in M199 based culture medium was stimulated with 1.0 g/ml BPC 157 for 30 min to induce the nitric oxide generation
This means good lab-tested research doses are precise and repeatable
US$ 22.30
US$ 21.30
US$ 24.70
